|The c3c n/a (Catalog #MBS573278) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. The Goat anti Human C3c, conjugated with FITC reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s C3c can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunocytochemistry (IHC), Immunohistochemistry (IHC), (In)direct Immunofluorescence (IF). Researchers should empirically determine the suitability of the c3c n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The c3c n/a product has the following accession number(s) (GI #82524318) (NCBI Accession #NP_001032313.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Background:In immunoelectrophoresis against fresh human serum, a single precipitin line is obtained in the beta-1 region
representing native C3. Against serum containing partly activated C3, a precipitin line is obtained which
extends from the beta-1 into the alpha-2 region, demonstrating a gradient. In old serum containing totally
activated C3 a single precipitin line in the alpha-2 region is obtained. Antisera to C3c cab also react with the
fragments C3b, C3bi and smaller fragments, since they all carry antigenic determinants of the C3c domain.
The product does not react with any other proteins component of human serum or plasma. The fluorescent
immunoconjugate to human C3c is used to determine the presence and pattern of C3 in tissue lesions using
immunohistochemical staining techniques. Locally deposited immune complexes in tissue usually contain
complement, pointing to activation of the classical pathway. Complement activation in vivo implies active
disease and may contribute to the elicitation of the pathogenesis and he extent of tissue destruction.
Sometimes the diagnosis can be based on directly on laboratory findings. This immunoconjugate is not prediluted.
The optimum working dilution of each conjugate should be established by titration before being used.
Excess labelled antibody must be avoided because it may cause high unspecific background staining and
interfere with the specific signal.
Product Type: Primary Antibodies
Source: C3c is the major fragment resulting from C3 cleavage by C3 convertase and factor I. It is composed of an intact beta chain bound to two fragments of the alpha chain. C3c is isolated and purified from pooled normal human serum. Freundís complete adjuvant is used in the first step of the immunization procedure.
Product: Fluorochrome-coupled purified hyperimmune IgG lyophilized from a solution in phosphate buffered saline
(PBS, pH 7.2) No preservative added, as it may interfere with the antibody activity.
Cross Reactivity: The antiSerum does not cross-react with any other component of Human plasma. Inter-species crossreactivity is a normal feature of antibodies to plasma proteins since they frequently share antigenic determinants. Cross-reactivity of this antiSerum has not been tested in detail.